{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:19:41Z","timestamp":1792685981777,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1124\/dmd.121.000640","type":"journal-article","created":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T20:00:14Z","timestamp":1636574414000},"page":"158-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["The Lack of Contribution of 7-Hydroxymitragynine to the Antinociceptive Effects of Mitragynine in Mice: A Pharmacokinetic and Pharmacodynamic Study"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2868-8073","authenticated-orcid":false,"given":"Erin C.","family":"Berthold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1664-1692","authenticated-orcid":false,"given":"Shyam H.","family":"Kamble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanumuri S.","family":"Raju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle A.","family":"Kuntz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandria S.","family":"Senetra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Mottinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5064-2381","authenticated-orcid":false,"given":"Francisco","family":"Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis F.","family":"Restrepo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avi","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas P.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takato","family":"Hiranita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0553-4039","authenticated-orcid":false,"given":"Abhisheak","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance R.","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"McCurdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.121.000640_bib1","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1055\/a-0770-3683","article-title":"Comparative pharmacokinetics of mitragynine after oral administration of Mitragyna speciosa (kratom) leaf extracts in rats","volume":"85","author":"Avery","year":"2019","journal-title":"Planta Med"},{"key":"10.1124\/dmd.121.000640_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108235","article-title":"Evaluation of the rewarding effects of mitragynine and 7- hydroxymitragynine in an intracranial self-stimulation procedure in male and female rats","volume":"215","author":"Behnood-Rod","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/dmd.121.000640_bib2","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1177\/074823379701300401","article-title":"Physiological parameter values for physiologically based pharmacokinetic models","volume":"13","author":"Brown","year":"1997","journal-title":"Toxicol Ind Health"},{"key":"10.1124\/dmd.121.000640_bib3","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1021\/acs.jnatprod.0c01055","article-title":"Exploring the chemistry of alkaloids from Malaysian Mitragyna speciosa (kratom) and the role of oxindoles on human opioid receptors","volume":"84","author":"Chear","year":"2021","journal-title":"J Nat Prod"},{"key":"10.1124\/dmd.121.000640_bib4","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/00008877-200112000-00003","article-title":"Receptor-selective antagonism of opioid antinociception in female versus male rats","volume":"12","author":"Craft","year":"2001","journal-title":"Behav Pharmacol"},{"key":"10.1124\/dmd.121.000640_bib5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/109158101317097746","article-title":"Gender-based differences in pharmacokinetics in laboratory animal models","volume":"20","author":"Czerniak","year":"2001","journal-title":"Int J Toxicol"},{"key":"10.1124\/dmd.121.000640_bib6","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1023\/A:1011907920641","article-title":"Modeling of pharmacokinetic\/pharmacodynamic (PK\/PD) relationships: concepts and perspectives","volume":"16","author":"Derendorf","year":"1999","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.121.000640_bib7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s40122-020-00151-x","article-title":"Kratom-pharmacology, clinical implications, and outlook: a comprehensive review","volume":"9","author":"Eastlack","year":"2020","journal-title":"Pain Ther"},{"key":"10.1124\/dmd.121.000640_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229646","article-title":"Evaluating kratom alkaloids using PHASE","volume":"15","author":"Ellis","year":"2020","journal-title":"PLoS One"},{"key":"10.1124\/dmd.121.000640_bib9","series-title":"Bioanalytical Method Validation Guidance for Industry.","year":"2018"},{"key":"10.1124\/dmd.121.000640_bib10","series-title":"FDA Adverse Events Reporting System (FAERS).","year":"2021"},{"key":"10.1124\/dmd.121.000640_bib11","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1472-8206.2004.00246.x","article-title":"Is it important to correct apparent drug tissue concentrations for blood contamination in the dog?","volume":"18","author":"Giudicelli","year":"2004","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1124\/dmd.121.000640_bib12","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/adb.12639","article-title":"Abuse liability and therapeutic potential of the Mitragyna speciosa (kratom) alkaloids mitragynine and 7-hydroxymitragynine","volume":"24","author":"Hemby","year":"2019","journal-title":"Addict Biol"},{"key":"10.1124\/dmd.121.000640_bib13","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1007\/s00213-019-05247-7","article-title":"The effects of mitragynine and morphine on schedule-controlled responding and antinociception in rats","volume":"236","author":"Hiranita","year":"2019","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/dmd.121.000640_bib14","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2165\/00003088-198106060-00002","article-title":"Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models","volume":"6","author":"Holford","year":"1981","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/dmd.121.000640_bib15","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1080\/00498254.2018.1552819","article-title":"Metabolite profiling and identification of enzymes responsible for the metabolism of mitragynine, the major alkaloid of Mitragyna speciosa (kratom)","volume":"49","author":"Kamble","year":"2019","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.121.000640_bib16","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0196-9781(92)90096-L","article-title":"Sex differences in the effects of neuropeptide FF and IgG from neuropeptide FF on morphine- and stress-induced analgesia","volume":"13","author":"Kavaliers","year":"1992","journal-title":"Peptides"},{"key":"10.1124\/dmd.121.000640_bib17","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/0006-8993(90)90936-6","article-title":"Developmental changes in opiate-induced analgesia in deer mice: sex and population differences","volume":"516","author":"Kavaliers","year":"1990","journal-title":"Brain Res"},{"key":"10.1124\/dmd.121.000640_bib18","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0090-9556(25)07148-X","article-title":"Potential error in the measurement of tissue to blood distribution coefficients in physiological pharmacokinetic modeling. Residual tissue blood. I. Theoretical considerations","volume":"19","author":"Khor","year":"1991","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.121.000640_bib19","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1021\/acscentsci.9b00141","article-title":"7-Hydroxymitragynine is an active metabolite of mitragynine and a key mediator of its analgesic effects","volume":"5","author":"Kruegel","year":"2019","journal-title":"ACS Cent Sci"},{"key":"10.1124\/dmd.121.000640_bib20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1744-8069-9-45","article-title":"Sex differences in opioid analgesia and addiction: interactions among opioid receptors and estrogen receptors","volume":"9","author":"Lee","year":"2013","journal-title":"Mol Pain"},{"key":"10.1124\/dmd.121.000640_bib21","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1159\/000494644","article-title":"Sex associated differential expressions of the alternatively spliced variants mRNA of OPRM1 in brain regions of C57BL\/6 mouse","volume":"50","author":"Liu","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"10.1124\/dmd.121.000640_bib22","doi-asserted-by":"crossref","first-page":"14007","DOI":"10.1523\/JNEUROSCI.4123-08.2008","article-title":"Sex differences in micro-opioid receptor expression in the rat midbrain periaqueductal gray are essential for eliciting sex differences in morphine analgesia","volume":"28","author":"Loyd","year":"2008","journal-title":"J Neurosci"},{"key":"10.1124\/dmd.121.000640_bib23","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s13181-016-0588-y","article-title":"Suspected adulteration of commercial kratom products with 7-hydroxymitragynine","volume":"12","author":"Lydecker","year":"2016","journal-title":"J Med Toxicol"},{"key":"10.1124\/dmd.121.000640_bib24","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1055\/s-0034-1382760","article-title":"Evaluation of in vitro absorption, distribution, metabolism, and excretion (ADME) properties of mitragynine, 7-hydroxymitragynine, and mitraphylline","volume":"80","author":"Manda","year":"2014","journal-title":"Planta Med"},{"key":"10.1124\/dmd.121.000640_bib25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0014-2999(96)00714-5","article-title":"Central antinociceptive effects of mitragynine in mice: contribution of descending noradrenergic and serotonergic systems","volume":"317","author":"Matsumoto","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/dmd.121.000640_bib26","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1055\/a-1212-5475","article-title":"Pharmacokinetics and safety of mitragynine in beagle dogs","volume":"86","author":"Maxwell","year":"2020","journal-title":"Planta Med"},{"key":"10.1124\/dmd.121.000640_bib27","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s13318-021-00684-2","article-title":"Oral pharmacokinetics in beagle dogs of the mitragynine metabolite, 7-hydroxymitragynine","volume":"46","author":"Maxwell","year":"2021","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1124\/dmd.121.000640_bib28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0014-2999(94)90543-6","article-title":"Morphine-induced straub tail response: mediated by central mu2-opioid receptor","volume":"263","author":"Nath","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/dmd.121.000640_bib29","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1021\/acs.jmedchem.9b01465","article-title":"Investigation of the adrenergic and opioid binding affinities, metabolic stability, plasma protein binding properties, and functional effects of selected indole-based kratom alkaloids","volume":"63","author":"Obeng","year":"2020","journal-title":"J Med Chem"},{"key":"10.1124\/dmd.121.000640_bib30","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1124\/jpet.120.000189","article-title":"Pharmacological comparison of mitragynine and 7-hydroxymitragynine: in vitro affinity and efficacy for \u03bc-opioid receptor and opioid-like behavioral effects in rats","volume":"376","author":"Obeng","year":"2021","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.121.000640_bib31","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1001\/jama.1988.03720090052035","article-title":"Multiple morphine and enkephalin receptors and the relief of pain","volume":"259","author":"Pasternak","year":"1988","journal-title":"JAMA"},{"key":"10.1124\/dmd.121.000640_bib32","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1002\/dta.2604","article-title":"Simultaneous quantification of ten key kratom alkaloids in Mitragyna speciosa leaf extracts and commercial products by ultra-performance liquid chromatography-tandem mass spectrometry","volume":"11","author":"Sharma","year":"2019","journal-title":"Drug Test Anal"},{"key":"10.1124\/dmd.121.000640_bib33","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/17425255.2021.1853706","article-title":"Assessing the therapeutic potential and toxicity of Mitragyna speciosa in opioid use disorder","volume":"17","author":"Sharma","year":"2021","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1124\/dmd.121.000640_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2019.112462","article-title":"Patterns and reasons for kratom (Mitragyna speciosa) use among current and former opioid poly-drug users","volume":"249","author":"Singh","year":"2020","journal-title":"J Ethnopharmacol"},{"key":"10.1124\/dmd.121.000640_bib35","series-title":"Statistical Methods","author":"Snedecor","year":"1967"},{"key":"10.1124\/dmd.121.000640_bib36","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0304-3959(02)00041-6","article-title":"The interaction index: a measure of drug synergism","volume":"98","author":"Tallarida","year":"2002","journal-title":"Pain"},{"key":"10.1124\/dmd.121.000640_bib43","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1038\/npp.2016.91","article-title":"Lack of specific unvolvement of (+)-naloxone and (+)-naltrexone on the reinforcing and neurochemical effects of cocaine and opioids","volume":"41","author":"Tanda","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/dmd.121.000640_bib37","doi-asserted-by":"crossref","first-page":"8381","DOI":"10.1021\/acs.jmedchem.6b00748","article-title":"Mitragynine\/corynantheidine pseudoindoxyls as opioid analgesics with mu agonism and delta antagonism, which do not recruit \u03b2-arrestin-2","volume":"59","author":"V\u00e1radi","year":"2016","journal-title":"J Med Chem"},{"key":"10.1124\/dmd.121.000640_bib38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2147\/SAR.S164261","article-title":"Current perspectives on the impact of kratom use","volume":"10","author":"Veltri","year":"2019","journal-title":"Subst Abuse Rehabil"},{"key":"10.1124\/dmd.121.000640_bib39","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/rcm.1777","article-title":"A novel liquid chromatography\/tandem mass spectrometry based depletion method for measuring red blood cell partitioning of pharmaceutical compounds in drug discovery","volume":"19","author":"Yu","year":"2005","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1124\/dmd.121.000640_bib40","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1007\/s00213-018-4974-9","article-title":"Abuse liability of mitragynine assessed with a self-administration procedure in rats","volume":"235","author":"Yue","year":"2018","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/dmd.121.000640_bib41","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/adb.12661","article-title":"Rate and extent of mitragynine and 7-hydroxymitragynine blood-brain barrier transport and their intra-brain distribution: the missing link in pharmacodynamic studies","volume":"24","author":"Yusof","year":"2019","journal-title":"Addict Biol"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624007360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624007360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.121.000640","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T08:51:48Z","timestamp":1739955108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624007360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S0090955624007360"],"URL":"https:\/\/doi.org\/10.1124\/dmd.121.000640","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Lack of Contribution of 7-Hydroxymitragynine to the Antinociceptive Effects of Mitragynine in Mice: A Pharmacokinetic and Pharmacodynamic Study","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.121.000640","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}